Brief: Rubra Medicaments Gets Shareholders' Nod For Appointment Of Sunil Khandalwal As MD
01/10/2018 10:28
Oct 1 (Reuters) - Rubra Medicaments Ltd RUBR.BO :
* GETS SHAREHOLDERS' NOD FOR APPOINTMENT OF SUNIL
KHANDALWAL AS
MANAGING DIRECTOR OF THE COMPANY
Source text - https://reut.rs/2ReY0DN
Further company coverage: RUBR.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Checkpoint Trends
See all newsBrief: Checkpoint Trends To Evaluate Revised Proposal For Raising Funds
Brief: Checkpoint Trends Says Abha Rajesh Kapoor Resigns As Whole-Time Director And CFO
Brief: Checkpoint Trends Approves Issue Of Equity Shares Through QIP For 5 Billion Rupees
Brief: Rubra Medicaments Gets Shareholders' Nod For Appointment Of Sunil Khandalwal As MD
Brief: Rubra Medicaments' MD Atul Anand Resigns